BioPharma Dive1 min read
saveStar raises $200 million after successful spinouts of Electra and Vega Therapeutics
read at BioPharma Dive ↗DealPositive
Star, a biopharma company, announced it has secured $200 million in new funding.
The capital follows the recent exits of its subsidiaries Electra Therapeutics and Vega Therapeutics, which were spun out of the parent.
Star said the proceeds will be used to pursue a new drug prospect, though no further details were provided.
source
This writeup was produced by pharmadog from original reporting by BioPharma Dive.
Original headline: “Star adds $200M after spinout successes”
read at BioPharma Dive ↗546 words · retrieved 17m ago
comments(0)
5-min edit window · permanent after that